July 19, 2024

The Growing Use Of Eco-Friendly Materials Is Anticipated To Open Up The New Avenue For Non-PVC IV Bags Market

Market Overview:

 

Non-PVC IV bags are medical devices used for administering fluids, blood, and medications intravenously. They are manufactured using materials such as polypropylene, polyethylene, and EVA/ethylene vinyl acetate which provide greater stability and are more environmentally sustainable than traditional PVC materials. Non-PVC IV bags find widespread application in hospitals, clinics, and ambulatory surgical centers for delivering isotonic fluids like saline, dextrose, ringer’s lactate to treat conditions like dehydration and regulating fluid and electrolyte balance in patients.

Market Dynamics:

Increasing concerns regarding health hazards from exposure to toxic plasticizers like DEHP in PVC materials is a key driver bolstering the demand for non-PVC alternatives in the healthcare sector. Further, strict regulatory standards on use of hazardous chemicals like REACH are also prompting leading manufacturers to shift towards eco-friendly product lines. Additionally, the rising patient volume due to growing prevalence of chronic and infectious diseases is augmenting the need for effective fluid administration procedures, propelling the sales of non-PVC IV bags. Technical advancements enabling manufacture of non-PVC bags offering improved permeability, biocompatibility as well as compatibility with varied medications also support the industry expansion.

 

Segment Analysis

 

The global non-PVC IV bags market can be segmented based on material type, application, end use and region. Based on material type, the market is dominated by the ethyl vinyl acetate segment which holds around 40% share of the total market. Ethyl vinyl acetate is the leading material for manufacturing non-PVC IV bags due to its good transparency, flexibility and puncture resistance properties.

PEST Analysis

 

Political: Regulations around environmental protection and healthcare safety are encouraging the usage of non-PVC materials in medical devices like IV bags. This is positively impacting the non-PVC IV bags market.

Economic: The growing healthcare spending across developed and developing nations is fueling the demand for better healthcare products and services. This is propelling the non-PVC IV bags market forward.

Social: Increasing awareness about environmental protection and repercussions of PVC usage is driving consumers towards non-PVC healthcare products like IV bags.

Technological: Advancements in materials science are paving way for new safer and high-performance options to replace PVC in medical devices. This is helping the adoption non-PVC IV bags.

Key Takeaways

 

The Global Non-PVC IV Bags Market Size is expected to witness high growth, exhibiting CAGR of 9.5% over the forecast period, due to increasing patient preference for safer medical products. The market size for non-PVC IV bags is projected to reach US$ 4102.39 Mn by 2030 from US$ 2164.96 Mn in 2023.

Regional analysis:

 

North America dominates the non-PVC IV bags market with over 30% share owing to developed healthcare infrastructure and stringent regulations around medical waste in the region. Asia Pacific is poised to witness fastest growth during the forecast period due to growing healthcare spending, healthcare modernization and expanding patient pool in the region.

Key players:

 

Key players operating in the non-PVC IV bags market are Renolit SE, Kraton Corporation, Shanghai Solve Care Co., Ltd., Shanghai Xin Gen Eco-Technologies Co., Ltd., PolyCine GmbH, Jiangxi Sanxin Medtec Co., Ltd., Sealed Air, Baxter, B. Braun Melsungen AG, Sichuan Kelun Pharmaceutical Co., Ltd., Fresenius Kabi AG, Otsuka Holdings Co., Ltd., Sartorius AG, Technoflex, and Huaren Pharmaceutical Co., Ltd. These companies are focusing on new product launches and geographic expansion to consolidate their position in the market.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it